Management of myocardial infarction in Spain in the year 2000.: The PRIAMHO II Study

被引:61
作者
Arós, F
Cuñat, J
Loma-Osorio, A
Torrado, E
Bosch, X
Rodríguez, JJ
Bescós, LL
Ancillo, P
Pabón, P
Heras, M
Marrugat, J
机构
[1] Hosp Txagorritxu, Area Cardiol & Crit, Vitoria 01009, Alava, Spain
[2] Hosp La Fe, Serv Med Intens, E-46009 Valencia, Spain
[3] Hosp Clin Barcelona, Inst Clin Malalties Cardiovasc, Serv Cardiol, Barcelona, Spain
[4] Hosp Carlos Haya, Serv Cuidados Crit & Urgencias, Malaga, Spain
[5] Fundac Alcorcon, Unidad Cardiol, Madrid, Spain
[6] Gen Hosp, Unidad Med Intens, Segovia, Spain
[7] Univ Hosp, Serv Cardiol, Salamanca, Spain
[8] Inst Municipal Invest Med, Unitat Lipids & Epidemiol Cardiovasc, E-08003 Barcelona, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2003年 / 56卷 / 12期
关键词
myocardial infarction; acute coronary syndromes registry; management; reperfusion therapy mortality; risk stratification; secondary prevention;
D O I
10.1157/13055334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives. Hospital registries are useful tools to measure the degree of implementation of new treatments and clinical practice guidelines. Patients and method. The hospital registry described here was developed in the prospective PRIAMHO 11 study, which involved a random selection of Spanish hospitals with a coronary intensive care unit and external quality control. This study investigated patients admitted to the coronary care unit with acute myocardial infarction. Demographic and clinical characteristics were recorded, as well as the management, clinical course and survival after 28 days and one year. Results. From May 15 to December 15 2000 we included in the registry 6,221 patients from the 58 hospitals that complied with the quality control requirements (71.6% of all participating hospitals). Acute mortality was 9.6%; 28-day and one-year mortality were 11.4% and 16.5%, respectively. Of the patients with ST elevation-myocardial infarction of less than 12 hours' duration, 71.6% were reperfused and 89.3% received fibrinolysis with a median door-to-needle time of 48 minutes. Ejection fraction was measured in 81% of the patients, and 43% were tested for inducible ischemia. About nine-tenths (91%) of the patients were discharged on least one antiplatelet drug, 56% on a beta blocker, 45% on an ACE inhibitor, and 45% on a lipid-lowering agent, with a coefficient of variation between hospitals greater than 25% for the last three drugs. Conclusions. The percentage of patients with ST elevation treated with reperfusion should increase, as it probably will thanks to the increasing use of primary angioplasty. The door-to-needle time was longer than the recommended interval. In-hospital risk stratification was good but nonsystematic for the evaluation of ejection fraction, and unsatisfactory for inducible ischemia testing. At discharge the percentages of patients receiving beta blockers, ACE inhibitors and statins were not optimal, and there were wide variations in prescribing practices between hospitals.
引用
收藏
页码:1165 / 1173
页数:9
相关论文
共 31 条
  • [1] Are data from clinical registries of any value?
    Alpert, JS
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 (17) : 1399 - 1401
  • [2] Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
    Alpert, JS
    Antman, E
    Apple, F
    Armstrong, PW
    Bassand, JP
    de Luna, AB
    Beller, G
    Breithardt, G
    Chaitman, BR
    Clemmensen, P
    Falk, E
    Fishbein, MC
    Galvani, M
    Garson, A
    Grines, C
    Hamm, C
    Jaffe, A
    Katus, H
    Kjekshus, J
    Klein, W
    Klootwijk, P
    Lenfant, C
    Levy, D
    Levy, RI
    Luepker, R
    Marcus, F
    Näslund, U
    Ohman, M
    Pahlm, O
    Poole-Wilson, P
    Popp, R
    Alto, P
    Pyörälä, K
    Ravkilde, J
    Rehnquist, N
    Roberts, W
    Roberts, R
    Roelandt, J
    Rydén, L
    Sans, S
    Simoons, ML
    Thygesen, K
    Tunstall-Pedoe, H
    Underwood, R
    Uretsky, BF
    Van de Werf, F
    Voipio-Pulkki, LM
    Wagner, G
    Wallentin, L
    Wijns, W
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) : 959 - 969
  • [3] [Anonymous], 1979, Circulation, V59, P607
  • [4] Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction - Results of the thrombolysis in myocardial infarction (TIMI) 11B trial
    Antman, EM
    McCabe, CH
    Gurfinkel, EP
    Turpie, AGG
    Bernink, PJLM
    Salein, D
    de Luna, AB
    Fox, K
    Lablanche, JM
    Radley, D
    Premmereur, J
    Braunwald, E
    [J]. CIRCULATION, 1999, 100 (15) : 1593 - 1601
  • [5] Guidelines of the Spanish society of cardiology in acute myocardial infarction
    Arós, F
    Loma-Osorio, A
    Alonso, A
    Alonso, JJ
    Cabadés, A
    Coma-Canella, I
    García-Castrillo, L
    García, E
    de Sá, EL
    Pabón, P
    San José, JM
    Vera, A
    Worner, F
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 1999, 52 (11): : 919 - 956
  • [6] Management of myocardial infarction in Spain (1995-99).: Data from the Registry of the Ischaemic Heart Disease Working Group (RISCI) of the Spanish Society of Cardiology
    Arós, F
    Loma-Osorio, A
    Bosch, X
    Aracil, JG
    Bescós, LL
    Marrugat, J
    Rabón, P
    Palencia, M
    Worner, F
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2001, 54 (09): : 1033 - 1040
  • [7] 2002 update of the guidelines of the Spanish Society of Cardiology for unstable angina/without ST-segment elevation myocardial infarction
    Bescós, LL
    Borau, FA
    Corbi, RML
    Fillat, AC
    Bueno, H
    Alonso, JJ
    Canella, IC
    Loma-Osorio, A
    Fernández, JB
    Martorell, RM
    Fernández, JT
    Fernández-Ortiz, A
    de la Iglesia, JM
    Pérez, MP
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2002, 55 (06): : 631 - 642
  • [8] Use of thrombolytic treatment in patients with acute myocardial infarction in Spain.: Observations from the PRIAMHO study
    Bosch, X
    Sambola, A
    Arós, F
    López-Bescós, L
    Mancisidor, X
    Illa, J
    Claramonte, R
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2000, 53 (04): : 490 - 501
  • [9] Variability in management and short- and mid-term prognosis of myocardial infarction in Spain:: The PRIAMHO study
    Cabadés, A
    López-Bescós, L
    Arós, F
    Loma-Osorio, A
    Bosch, X
    Pabón, P
    Marrugat, J
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 1999, 52 (10): : 767 - 775
  • [10] New data on secondary prevention of myocardial infarction in Spain.: Results of the PREVESE II Study
    de Velasco, JA
    Cosín, J
    López-Sendón, JL
    de Teresa, E
    de Oya, M
    Sellers, MD
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2002, 55 (08): : 801 - 809